These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11753358)

  • 1. Fooling mother nature.
    Crystal RG
    Nat Biotechnol; 2002 Jan; 20(1):32-3. PubMed ID: 11753358
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystic fibrosis gene therapy trials and tribulations.
    Zeitlin PL
    Mol Ther; 2000 Jan; 1(1):5-6. PubMed ID: 10933904
    [No Abstract]   [Full Text] [Related]  

  • 3. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.
    Liu X; Jiang Q; Mansfield SG; Puttaraju M; Zhang Y; Zhou W; Cohn JA; Garcia-Blanco MA; Mitchell LG; Engelhardt JF
    Nat Biotechnol; 2002 Jan; 20(1):47-52. PubMed ID: 11753361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protein repair therapy in cystic fibrosis].
    Clément A; Tamalet A; Fauroux B; Epaud R
    Rev Prat; 2003 Jan; 53(2):163-6. PubMed ID: 12664848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental paradigm for early features of cystic fibrosis.
    Larson JE; Cohen JC
    Pediatr Pulmonol; 2005 Nov; 40(5):371-7. PubMed ID: 15830387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A-->G, 2751+2T-->A, 296+1G-->C, 1717-9T-->C-D565G) and one nonsense mutation (E822X) in the CFTR gene.
    Tzetis M; Efthymiadou A; Doudounakis S; Kanavakis E
    Hum Genet; 2001 Dec; 109(6):592-601. PubMed ID: 11810271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and reliable genotyping of polymorphic loci modifying correct splicing of CFTR pre-mRNA using mass spectrometry.
    Schaller A; von Känel T; Gehr B; Sanz J; Gallati S
    Eur J Hum Genet; 2007 Jan; 15(1):53-61. PubMed ID: 17024213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards gene therapy for cystic fibrosis: a clinical progress report.
    Alton EW; Geddes DM; Gill DR; Higgins CF; Hyde SC; Innes JA; Porteous DJ
    Gene Ther; 1998 Mar; 5(3):291-2. PubMed ID: 9614547
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on gene therapy for cystic fibrosis.
    Griesenbach U; Geddes DM; Alton EW
    Curr Opin Mol Ther; 2003 Oct; 5(5):489-94. PubMed ID: 14601517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel agents in cystic fibrosis.
    Storey S; Wald G
    Nat Rev Drug Discov; 2008 Jul; 7(7):555-6. PubMed ID: 18591977
    [No Abstract]   [Full Text] [Related]  

  • 11. Pre-clinical and clinical endpoint assays for cystic fibrosis gene therapy.
    Griesenbach U; Boyd AC;
    J Cyst Fibros; 2005 May; 4(2):89-100. PubMed ID: 15914096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
    Romey MC
    Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel length variant of the polypyrimidine tract within the splice acceptor site in intron 8 of the CFTR gene: consequences for genetic testing using standard assays.
    Viel M; Leroy C; Des Georges M; Claustres M; Bienvenu T
    Eur J Hum Genet; 2005 Feb; 13(2):136-8. PubMed ID: 15562283
    [No Abstract]   [Full Text] [Related]  

  • 14. Revisiting the mouse lung model for CF.
    Boyd AC; Porteous DJ
    Gene Ther; 2004 May; 11(9):737-8. PubMed ID: 14999230
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of the spectra of mutations and polymorphic loci of cystic fibrosis transmembrane conductance regulator in the population of Bashkortostan].
    Korytina GF; Viktorova TV; Baĭkova GV; Khusnutdinova EK
    Genetika; 2002 Sep; 38(9):1270-5. PubMed ID: 12391889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting.
    Bruscia E; Sangiuolo F; Sinibaldi P; Goncz KK; Novelli G; Gruenert DC
    Gene Ther; 2002 Jun; 9(11):683-5. PubMed ID: 12032687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Problems posed by genetic diseases: cystic fibrosis].
    Bellon G; Reix P
    Rev Prat; 2006 Apr; 56(8):883-90. PubMed ID: 16764250
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene delivery systems--gene therapy vectors for cystic fibrosis.
    Klink D; Schindelhauer D; Laner A; Tucker T; Bebok Z; Schwiebert EM; Boyd AC; Scholte BJ
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():203-12. PubMed ID: 15463959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways.
    Rose AC; Goddard CA; Colledge WH; Cheng SH; Gill DR; Hyde SC
    Gene Ther; 2002 Oct; 9(19):1312-20. PubMed ID: 12224014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mutation spectrum of the CFTR gene in mucoviscidosis patients from Bashkortostan].
    Korytina GF; Viktorova TV; Ivashchenko TE; Baranov VS; Khusnutdinova EK
    Mol Biol (Mosk); 2003; 37(1):61-7. PubMed ID: 12624947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.